"Organoplatinum Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Organic compounds which contain platinum as an integral part of the molecule.
Descriptor ID |
D009944
|
MeSH Number(s) |
D02.691.800
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Organoplatinum Compounds".
Below are MeSH descriptors whose meaning is more specific than "Organoplatinum Compounds".
This graph shows the total number of publications written about "Organoplatinum Compounds" by people in this website by year, and whether "Organoplatinum Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 10 | 1 | 11 |
1997 | 2 | 0 | 2 |
1998 | 2 | 0 | 2 |
1999 | 1 | 2 | 3 |
2000 | 1 | 0 | 1 |
2001 | 0 | 1 | 1 |
2003 | 5 | 4 | 9 |
2004 | 1 | 7 | 8 |
2005 | 4 | 8 | 12 |
2006 | 7 | 7 | 14 |
2007 | 4 | 6 | 10 |
2008 | 5 | 12 | 17 |
2009 | 5 | 11 | 16 |
2010 | 9 | 6 | 15 |
2011 | 6 | 15 | 21 |
2012 | 5 | 11 | 16 |
2013 | 6 | 11 | 17 |
2014 | 4 | 14 | 18 |
2015 | 3 | 11 | 14 |
2016 | 4 | 7 | 11 |
2017 | 3 | 10 | 13 |
2018 | 2 | 5 | 7 |
2019 | 1 | 3 | 4 |
2020 | 0 | 8 | 8 |
2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organoplatinum Compounds" by people in Profiles.
-
Biliary cancer: gateway to comprehensive molecular profiling. Clin Adv Hematol Oncol. 2021 Jan; 19(1):27-34.
-
Immunologic and tumor responses of pegilodecakin with 5-FU/LV and oxaliplatin (FOLFOX) in pancreatic ductal adenocarcinoma (PDAC). Invest New Drugs. 2021 02; 39(1):182-192.
-
Veliparib with carboplatin and paclitaxel in BRCA-mutated advanced breast cancer (BROCADE3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2020 10; 21(10):1269-1282.
-
The role of neoadjuvant chemotherapy in the management of low-grade serous carcinoma of the ovary and peritoneum: Further evidence of relative chemoresistance. Gynecol Oncol. 2020 09; 158(3):653-658.
-
Neoadjuvant Immunotherapy-Based Systemic Treatment in MMR-Deficient or MSI-High Rectal Cancer: Case Series. J Natl Compr Canc Netw. 2020 07; 18(7):798-804.
-
Surgical management of carcinomas of the infratemporal fossa and skull base: patterns of failure and predictors of long-term outcomes. J Neurosurg. 2020 Jun 12; 134(5):1392-1398.
-
FOLFOXIRI Versus Doublet Regimens in Right-Sided Metastatic Colorectal Cancer: Focus on Subsequent Therapies and Impact on Overall Survival. Clin Colorectal Cancer. 2020 12; 19(4):248-255.e6.
-
COVID-19 and ovarian cancer: Exploring alternatives to intravenous (IV) therapies. Gynecol Oncol. 2020 07; 158(1):34-36.
-
Decision analysis for secondline maintenance treatment of platinum sensitive recurrent ovarian cancer: a review. Int J Gynecol Cancer. 2020 05; 30(5):684-694.
-
Efficacy and Tolerability of Tremelimumab in Locally Advanced or Metastatic Urothelial Carcinoma Patients Who Have Failed First-Line Platinum-Based Chemotherapy. Clin Cancer Res. 2020 01 01; 26(1):61-70.